Three formats. One essential briefing.
Deal Watch
Every funding round, acquisition, and partnership across pediatric digital health, maternal health tech, NICU innovation, and value-based pediatric care. With context, not just headlines.
Policy Pulse
CMS quality measures, Medicaid/CHIP updates, FDA pediatric actions, COPPA enforcement, and state-level developments — translated from policy-speak into business impact.
Deep Dispatch
Original analysis on the trends reshaping maternal-pediatric health. Sector theses, market maps, and the kind of deep dives investors forward to their partners.
Read by professionals at 50+ health systems, VC firms, and maternal-pediatric health companies
in digital health funding in 2025
of digital health VC went to pediatric companies (up from 1.7%)
other publications dedicated to this space
Built for the people who decide what happens next.
Investors
VCs, growth equity, and PE professionals evaluating maternal-pediatric health tech opportunities. From seed to growth stage, Medicaid to commercial.
Operators
C-suite and VP+ leaders at pediatric health tech startups, maternal health platforms, and digital health companies expanding into family health.
Health System Leaders
CIOs, Chief Innovation Officers, and strategy executives at the 280+ children's hospitals and health systems serving pediatric populations.
Advisors & Consultants
Strategy consultants, policy advisors, and industry analysts working at the intersection of healthcare technology and children's health.
The intelligence briefing maternal-pediatric health tech has been missing.
Pediatric Health Dispatch exists because a $700 billion sector of healthcare — responsible for 74 million children — has no dedicated professional publication tracking the deals, policy shifts, and technology trends reshaping it.
We cover the full maternal-pediatric continuum: from fertility and pregnancy through birth, NICU, infant care, and childhood. From Medicaid reimbursement to Series C funding rounds. From CMS quality measures to FDA digital therapeutic approvals.
Built for the professionals making the biggest decisions about the smallest patients — investors allocating capital, operators building companies, and health system leaders adopting technology.
Start reading.
Free. Twice weekly. No spam, no fluff — just the deals, policy, and analysis that matter.
Unsubscribe anytime. We respect your inbox.